Acquisition of anoikis resistance reveals a synoikis-like survival style in BEL7402 hepatoma cells

Cancer Letters

Volumn 267, Issue 1, 2008, Pages 106-115

  Zhang, Zhiyong ^a   Cao, Lili ^a,b   Li, Jie ^b   Liang, Xiaohong ^a   Liu, Yugang ^a   Liu, Hua ^a   Du, Juan ^a   Qu, Zhonghua ^a   Cui, Min ^a   Liu, Suxia ^a   Gao, Lifen ^a   Ma, Chunhong ^a   Zhang, Lining ^a   Han, Lihui ^a   Sun, Wensheng ^a  

^a SHANDONG UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

ANGPTL4; Anoikis; Apoptosis; Hepatoma; Synoikis like

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE 4 PROTEIN; ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY DNA; FLUOROURACIL; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANOIKIS; APOPTOSIS; ARTICLE; CELL ADHESION; CELL CYCLE ARREST; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; METASTASIS; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANGIOPOIETINS; ANOIKIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSFECTION;

EID: 45849143655     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.03.010     Document Type: Article

References (26)

1. Sullivan R., and Graham C.H. Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev. (2007) 319-331
2. Rennebeck G., Martelli M., and Kyprianou N. Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis?. Cancer Res. 65 (2005) 11230-11235
3. Berezovskaya O., Schimmer A.D., Glinskii A.B., Pinilla C., Hoffman R.M., Reed J.C., and Glinsky G.V. Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells. Cancer Res. 65 (2005) 2378-2386
4. Reddig P.J., and Juliano R.L. Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev. 24 (2005) 425-439
5. Shen X., and Kramer R.H. Adhesion-mediated squamous cell carcinoma survival through ligand-independent activation of epidermal growth factor receptor. Am. J. Pathol. 165 (2004) 1315-1329
6. Lee H.J., Cho C.H., Hwang S.J., Choi H.H., Kim K.T., Ahn S.Y., Kim J.H., Oh J.L., Lee G.M., and Koh G.Y. Biological characterization of angiopoietin-3 and angiopoietin-4. FASEB J. 18 (2004) 1200-1208
7. Le Jan S., Amy C., Cazes A., Monnot C., Lamandé N., Favier J., Philippe J., Sibony M., Gasc J.M., Corvol P., and Germain S. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am. J. Pathol. 162 (2003) 1521-1528
8. Wang Y., Lam K.S., Lam J.B., Lam M.C., Leung P.T., Zhou M., and Xu A. Overexpression of angiopoietin-like protein 4 alters mitochondria activities and modulates methionine metabolic cycle in the liver tissues of db/db diabetic mice. Mol. Endocrinol. 21 (2007) 972-986
9. Sukonina V., Lookene A., Olivecrona T., and Olivecrona G. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc. Natl. Acad. Sci. USA 103 (2006) 17450-17455
10. Köster A., Chao Y.B., Mosior M., Ford A., Gonzalez-DeWhitt P.A., Hale J.E., Li D., Qiu Y., Fraser C.C., Yang D.D., Heuer J.G., Jaskunas S.R., and Eacho P. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 146 (2005) 4943-4950
11. Kim I., Kim H.G., Kim H., Kim H.H., Park S.K., Uhm C.S., Lee Z.H., Koh G.Y., and expression H. synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem. J. 346 (2000) 603-610
12. Liang X., Liu Y., Zhang Q., Gao L., Han L., Ma C., Zhang L., Chen Y.H., and Sun W. Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax. J. Immunol. 178 (2007) 503-510
13. Diaz-Montero C.M., and McIntyre B.W. Acquisition of anoikis resistance in human osteosarcoma cells does not alter sensitivity to chemotherapeutic agents. BMC Cancer 5 (2005) 39
14. Hong J.H., Noh K.M., Yoo Y.E., Choi S.Y., Park S.Y., Kim Y.H., and Chung J.M. Iron promotes the survival and neurite extension of serum-starved PC12 cells in the presence of NGF by enhancing cell attachment. Mol. Cells 15 (2003) 10-19
15. Zhu Z., Sanchez-Sweatman O., Huang X., Wiltrout R., Khokha R., Zhao Q., and Gorelik E. Anoikis and metastatic potential of cloudman S91 melanoma cells. Cancer Res. 61 (2001) 1707-1716
16. Joseph R.R., Yazer E., Hanakawa Y., and Stadnyk A.W. Prostaglandins and activation of AC/cAMP prevents anoikis in IEC-18. Apoptosis 10 (2005) 1221-1233
17. Zhang Y., Lu H., Dazin P., and Kapila Y. Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin alphav mediate survival signals through focal adhesion kinase. J. Biol. Chem. 279 (2004) 48342-48349
18. Collins N.L., Reginato M.J., Paulus J.K., Sgroi D.C., Labaer J., and Brugge J.S. G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression. Mol. Cell. Biol. 25 (2005) 5282-5291
19. Schmidt M., Hovelmann S., and Beckers T.L. A novel form of constitutively active farnesylated Akt1 prevents mammary epithelial cells from anoikis and suppresses chemotherapy-induced apoptosis. Br. J. Cancer 87 (2002) 924-932
20. Ravi R., Fuchs E.J., Jain A., Pham V., Yoshimura K., Prouser T., Jalla S., Zhou X., Garrett-Mayer E., Kaufmann S.H., Schulick R.D., Pardoll D.M., and Bedi A. Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial death signaling. Cancer Res. 66 (2006) 1730-1739
21. Gibson L., Holmgreen S.P., Huang D.C., Bernard O., Copeland N.G., Jenkins N.A., Sutherland G.R., Baker E., Adams J.M., and Cory S. bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene 13 (1996) 665-675
22. Vande Velde C., Cizeau J., Dubik D., Alimonti J., Brown T., Israels S., Hakem R., and Greenberg A.H. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol. Cell. Biol. 20 (2000) 5454-5468
23. Weinzimer S.A., Gibson T.B., Collett-Solberg P.F., Khare A., Liu B., and Cohen P. Transferrin is an insulin-like growth factor-binding protein-3 binding protein. J. Clin. Endocrinol. Metab. 86 (2001) 1806-1813
24. Merdek K.D., Yang X., Taglienti C.A., Shaw L.M., and Mercurio A.M. Intrinsic signaling functions of the beta4 integrin intracellular domain. J. Biol. Chem. 282 (2007) 30322-30330
25. Swietach P., Vaughan-Jones R.D., and Harris A.L. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev. 26 (2007) 299-310
26. McColl B.K., and Stacker S.A. Achen MG.Molecular regulation of the VEGF family - inducers of angiogenesis and lymphangiogenesis. APMIS 112 (2004) 463-480